CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LISINOPRIL: products 41 to 45 of 45.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Teva-Lisinopril (Type Z) 20mg TabDIN 02285134 | General benefit | $0.1945per source unit | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril (Type Z) 5mg TabDIN 02285118 | General benefit | $0.1347per source unit | Requirements & sourcesBuild cost plan |
| Zestril 10mg TabDIN 02049376 | General benefit | $0.1619per source unit | Requirements & sourcesBuild cost plan |
| Zestril 20mg TabDIN 02049384 | General benefit | $0.1945per source unit | Requirements & sourcesBuild cost plan |
| Zestril 5mg TabDIN 02049333 | General benefit | $0.1347per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.